TR200200506T2 - Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem - Google Patents

Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem

Info

Publication number
TR200200506T2
TR200200506T2 TR2002/00506T TR200200506T TR200200506T2 TR 200200506 T2 TR200200506 T2 TR 200200506T2 TR 2002/00506 T TR2002/00506 T TR 2002/00506T TR 200200506 T TR200200506 T TR 200200506T TR 200200506 T2 TR200200506 T2 TR 200200506T2
Authority
TR
Turkey
Prior art keywords
production
clusters
telithromycin
spherical
spherical telithromycin
Prior art date
Application number
TR2002/00506T
Other languages
English (en)
Turkish (tr)
Inventor
Godard Jean-Yves
Rognon - Ravaux Val�Rie
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200200506(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of TR200200506T2 publication Critical patent/TR200200506T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2002/00506T 1999-08-26 2000-08-28 Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem TR200200506T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
TR200200506T2 true TR200200506T2 (tr) 2002-08-21

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00506T TR200200506T2 (tr) 1999-08-26 2000-08-28 Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem

Country Status (34)

Country Link
US (1) US6825218B1 (enExample)
EP (1) EP1212336B1 (enExample)
JP (1) JP4871467B2 (enExample)
KR (1) KR100718222B1 (enExample)
CN (1) CN1183151C (enExample)
AR (1) AR025398A1 (enExample)
AT (1) ATE255590T1 (enExample)
AU (1) AU774385B2 (enExample)
BR (1) BR0013569B1 (enExample)
CA (1) CA2382497C (enExample)
CO (1) CO5190666A1 (enExample)
CZ (1) CZ2002594A3 (enExample)
DE (1) DE60006976T2 (enExample)
DK (1) DK1212336T3 (enExample)
EA (1) EA005080B1 (enExample)
ES (1) ES2209970T3 (enExample)
FR (1) FR2797875B1 (enExample)
HK (1) HK1049167B (enExample)
HR (1) HRP20020167B1 (enExample)
HU (1) HU229075B1 (enExample)
IL (2) IL148128A0 (enExample)
ME (2) MEP20108A (enExample)
MX (1) MXPA02001988A (enExample)
NO (1) NO322622B1 (enExample)
PL (1) PL204100B1 (enExample)
PT (1) PT1212336E (enExample)
RS (1) RS50433B (enExample)
SI (1) SI1212336T1 (enExample)
SK (1) SK287588B6 (enExample)
TR (1) TR200200506T2 (enExample)
TW (1) TWI272949B (enExample)
UA (1) UA73523C2 (enExample)
WO (1) WO2001014393A2 (enExample)
ZA (1) ZA200201599B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
BR0215806A (pt) * 2002-07-19 2005-04-26 Aventis Pharma Sa Composição oral de telitromicina com paladar mascarado
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
EP1610878B1 (en) * 2003-02-21 2014-09-03 University Of Bath Process for the production of particles
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468336D1 (en) * 1983-06-22 1988-02-11 Univ Ohio State Res Found Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU7018100A (en) 2001-03-19
CA2382497C (fr) 2011-06-28
CZ2002594A3 (cs) 2002-09-11
SK287588B6 (sk) 2011-03-04
SK2532002A3 (en) 2002-09-10
HK1049167B (zh) 2005-08-19
US6825218B1 (en) 2004-11-30
FR2797875B1 (fr) 2001-10-19
IL148128A (en) 2006-10-31
ATE255590T1 (de) 2003-12-15
UA73523C2 (uk) 2005-08-15
HUP0202842A3 (en) 2003-03-28
WO2001014393A3 (fr) 2001-06-21
KR100718222B1 (ko) 2007-05-15
NO20020926L (no) 2002-02-26
DK1212336T3 (da) 2004-03-15
CN1183151C (zh) 2005-01-05
DE60006976T2 (de) 2004-10-21
PL353137A1 (en) 2003-10-20
KR20020033771A (ko) 2002-05-07
HUP0202842A2 (hu) 2003-01-28
JP4871467B2 (ja) 2012-02-08
YU13202A (sh) 2004-09-03
CO5190666A1 (es) 2002-08-29
CA2382497A1 (fr) 2001-03-01
MEP20108A (en) 2010-06-10
CN1371386A (zh) 2002-09-25
BR0013569A (pt) 2002-05-14
ME00112B (me) 2010-10-10
RS50433B (sr) 2009-12-31
ES2209970T3 (es) 2004-07-01
AR025398A1 (es) 2002-11-27
EA005080B1 (ru) 2004-10-28
MXPA02001988A (es) 2002-08-20
PT1212336E (pt) 2004-04-30
HK1049167A1 (en) 2003-05-02
ZA200201599B (en) 2003-04-30
HRP20020167B1 (en) 2006-06-30
DE60006976D1 (de) 2004-01-15
WO2001014393A2 (fr) 2001-03-01
TWI272949B (en) 2007-02-11
FR2797875A1 (fr) 2001-03-02
PL204100B1 (pl) 2009-12-31
IL148128A0 (en) 2002-09-12
EP1212336A2 (fr) 2002-06-12
HU229075B1 (hu) 2013-07-29
BR0013569B1 (pt) 2014-02-25
NO20020926D0 (no) 2002-02-26
HRP20020167A2 (en) 2003-06-30
SI1212336T1 (en) 2004-04-30
EP1212336B1 (fr) 2003-12-03
NO322622B1 (no) 2006-11-06
AU774385B2 (en) 2004-06-24
JP2003507484A (ja) 2003-02-25
EA200200294A1 (ru) 2002-08-29

Similar Documents

Publication Publication Date Title
AU2003283839A1 (en) Heteropolyacid and/or its salt supported catalyst, production process of the catalyst and production process of compound using the catalyst
NO20000841L (no) N-Aroylfenylalanin-derivater
AU5001599A (en) Gel-coated microcapsules
BR0011489A (pt) Composições formadoras de pelìcula compreendendo amidos modificados e iota-carragenano e processos para a fabricação de cápsulas macias usando as mesmas
AT504347B8 (de) Verfahren zur herstellung von glucosederivaten
AU3436601A (en) Decoding of array sensors with microspheres
TR200001472T2 (tr) 8-metoksi-kuinolon-karboksilik asitlerin hazırlanması için yöntem
YU4402A (sh) Novi derivati vitamina d sa cikličnim podstrukturama u bočnim lancima, postupak i međuproizvodi za njihovu proizvodnju i primena za proizvodnju lekova
NO20010516D0 (no) Krystallmodifisering av liponsyre
WO2001014393A3 (fr) Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
NO20074208L (no) Ammoniumnitrat granuler og fremgangsmate for fremstilling derav
ES2097103T5 (es) Metodo para producir almidon cationico.
NO20004919D0 (no) FremgangsmÕte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
EP1277755A4 (en) OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT BY AXIAL ASYMMETRY, METHOD FOR THE PRODUCTION THEREOF, AND THEIR APPLICATION IN THE ASYMMETRIC SYNTHESIS OF ALPHA-AMINO-ACID DERIVATIVES
WO2003014428A3 (fr) Procede d'obtention d'un monocristal de cdte ou de cdznte, et monocristal obtenu par ce procede
Salvo et al. Modulation of aortic protein phosphatase activity by polylysine
EP0260093A3 (en) Methods for production of cellulose i involving in vitro synthesis
AU2002224680A1 (en) Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product
NZ513163A (en) Method for rapidly obtaining crystals with desirable morphologies
WO2000047723A3 (en) Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
WO2004092188A3 (en) Analogs of lysophosphatidic acid and methods of making and using thereof
MY137098A (en) A method for the production of sugar comprising treating cereal powder material with transglutaminase
TR200001070A2 (tr) İzosiyanat içeren bağlayıcılar.
WO2003080820A3 (en) Mammalian permanent growth factor-independent cell line and method of its production
ICHIKAWA et al. Purification and properties of acetate kinase from Propionibacterium freudenreichii